Initial Testing for Suspected Infectious Mononucleosis
Begin evaluation with a complete blood count with differential and a rapid heterophile antibody (Monospot) test as the first-line screening approach for suspected infectious mononucleosis. 1, 2
First-Line Laboratory Testing
- Order a CBC with differential to assess for lymphocytosis (≥50% of WBC differential) and atypical lymphocytes (≥10% of total lymphocyte count), which support the diagnosis. 2, 3
- Simultaneously obtain a rapid heterophile antibody (Monospot) test, which has a sensitivity of 87% and specificity of 91% in the appropriate population. 2, 3
- A positive Monospot result is considered diagnostic for acute EBV infection and eliminates the need for further EBV-specific serologic testing. 1
Timing and Interpretation of Heterophile Testing
- The heterophile test typically becomes positive between days 6 and 10 after symptom onset; false-negative results are common during the first week of illness. 1, 2
- Overall, false-negative heterophile results occur in approximately 10% of patients. 1, 2
- In children younger than 10 years, the false-negative rate is markedly higher, and EBV-specific antibody testing should be performed directly rather than relying on heterophile testing. 1, 2, 4
- In adolescents and young adults (15-24 years), heterophile testing is more reliable and cost-effective. 2, 3
When to Proceed to EBV-Specific Serology
- When the Monospot test is negative but clinical suspicion remains high, proceed directly to EBV-specific antibody testing instead of repeating the heterophile assay. 1, 2
- Order all three EBV-specific antibodies together as a panel:
Interpretation of EBV-Specific Antibody Panel
- Acute primary infection pattern: VCA IgM positive + VCA IgG positive + EBNA negative. 1, 2
- Past infection pattern (>6 weeks prior): VCA IgG positive + EBNA positive + VCA IgM negative, which effectively rules out acute mononucleosis as the cause of current symptoms. 1, 2
- EBNA antibodies develop 1-2 months after primary infection and persist for life. 1, 2
- VCA IgG antibodies appear early in the acute phase and rise rapidly during infection. 1
Common Pitfalls to Avoid
- Do not rely solely on heterophile testing in children <10 years because of the high false-negative risk. 1, 2
- Do not obtain a single negative heterophile result during the first week of illness and use it to exclude mononucleosis; either repeat after 7-10 days or proceed directly to EBV serology. 2
- Be aware that false-positive heterophile results can occur in patients with leukemia, pancreatic carcinoma, viral hepatitis, or CMV infection. 1, 2
- Recognize that 5-10% of EBV-infected individuals may fail to develop EBNA antibodies, which should be considered when interpreting serology. 1
Supportive Laboratory Findings
- Liver function tests (AST, ALT, bilirubin) are elevated in roughly 90% of infectious mononucleosis cases and can reinforce the diagnosis when heterophile testing is negative. 2
- Peripheral blood leukocytosis with lymphocytes comprising at least 50% of the WBC differential and atypical lymphocytes >10% of total lymphocyte count strongly support the diagnosis. 2, 5
Alternative Diagnoses to Consider
- When both heterophile and EBV testing are negative, consider testing for other mononucleosis-like illnesses:
Special Populations Requiring Modified Approach
- In immunocompromised patients (transplant recipients, HIV-infected individuals, congenital immunodeficiencies), quantitative EBV viral load testing by nucleic acid amplification (NAAT) is preferred over serology for diagnosis and monitoring. 1, 2
- An EBV DNA load exceeding 10^2.5 copies per mg of peripheral blood mononuclear cell DNA signifies active infection and warrants close monitoring for lymphoproliferative disease. 1